K231353

Substantially Equivalent

AccuCTP Pro

Applicant: ArteryFlow Technology Co., Ltd.
Product code: LLZ
Advisory panel: Radiology
Date received: 2023-05-10
Decision date: 2023-09-14
Decision: Substantially Equivalent
Clearance type: Special
Location: Hangzhou City, CN

Adverse events under product code LLZ

product code LLZ

Death: 13
Total: 13

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.